CD8A and neoplasm: Among the MSI nonresponders, 16.0% (n = 21) showed insufficient tumor-infiltrating CD8+ T cells and 16.8% (n = 22) showed sufficient tumor-infiltrating CD8+ T cells; however, those CD8+ T cells display patterns of terminally exhausted CD8+ T cells.